Table 3.
Control (n = 21) |
Experimental (n = 23) |
||||||||
---|---|---|---|---|---|---|---|---|---|
4 h | POD1 | POD2 | POD3 | Any SE | 4 h | POD1 | POD2 | POD3 | Any SE |
0 | N/Dz | Dz | Dz | 1 | 0 | 0 | N | 0 | 1 |
N/V | N/V | N/V/Dz | Dz | 1 | Cf | Cf | Cf | Dz | 1 |
0 | Dz | Dz | 0 | 1 | 0 | N/V/Dz | N/V/Dz | 0 | 1 |
0 | 0 | 0 | 0 | 0 | 0 | P/Dz | N/Dz | 0 | 1 |
0 | 0 | 0 | 0 | 0 | 0 | Dz | 0 | 0 | 1 |
0 | Dw | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
0 | Dz | Dw | 0 | 1 | 0 | Dz | 0 | 0 | 1 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0 | N | 0 | 0 | 1 | 0 | Dz | 0 | 0 | 1 |
Dw | Dw | Dw | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0 | Dz | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | C | 1 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 0 | P | 1 | N | 0 | 0 | 0 | 1 |
0 | V | 0 | 0 | 1 | 0 | N | 0 | 0 | 1 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | Dz | 0 | 1 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
0 | 0 | 0 | 0 | 0 | |||||
0 | N | 0 | 0 | 1 | |||||
9.52% | 42.86% | 23.81% | 14.28% | 47.62% | 8.70% | 34.78% | 21.74% | 8.70% | 52.17% |
Table shows the percentages of control and experimental group subjects experiencing opioid side effects (SE) at each time interval: 4 h, postoperative days (POD) 1, 2 and 3, and total of any SE per group. There were no significant differences between the groups at 4 h even though a significant difference in opioid consumption was seen. Opioid side effects: (C) constipation; (Cf) confusion; (Dz) dizziness; (Dw) drowsiness; (N) nausea; (P) pruritus; (V) vomiting.